Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2024-12-19 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
LGP to acquire Health House distribution business 2 pages 328.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 20 December 2024, detailing Little Green Pharma Ltd's binding letter of intent to acquire the Health House distribution business. It includes terms of the transaction, purchase price, exclusivity period, and strategic rationale. There are no financial statements, quarterly or annual results, or detailed financial analysis. The content focuses on a corporate acquisition transaction announcement rather than a full merger filing or tender offer document. It is not a full merger proxy or tender offer form (MA), but rather an announcement of an acquisition intent. Therefore, the most appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes including acquisitions.
2024-12-19 English
Key changes to WA medicinal cannabis practices 2 pages 334.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 December 2024 from Little Green Pharma Ltd. It discusses recent regulatory changes in Western Australia's medicinal cannabis dispensing and prescribing practices and their impact on the company. The content focuses on regulatory updates and operational impact rather than financial results, management changes, or shareholder voting. The document is relatively short (about 5,000 characters) and serves as a regulatory update announcement rather than a detailed financial or management report. It does not contain financial statements, audit information, or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-18 English
Denmark positioned as EU medicinal cannabis hub 3 pages 306.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 December 2024 from Little Green Pharma Ltd. It discusses the Danish government's agreement to make the medicinal cannabis pilot program permanent and outlines strategic advancements in cultivation, export rules, and patient access. The content focuses on regulatory changes, market positioning, and strategic alignment with European markets. There are no financial statements, quarterly or annual results, nor is there any indication of a report being attached or published. The document is a corporate announcement about regulatory and strategic developments rather than a financial report or management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a call transcript, audit report, or legal proceeding update. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about government policy changes affecting the company and its market environment, which does not fit more specific categories.
2024-12-04 English
Half Yearly Report and Accounts 30 pages 909.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Little Green Pharma Ltd Appendix 4D Half-year report' and references the half-year ended 30 September 2024, indicating it is a financial report for a period shorter than a full fiscal year. It contains detailed financial statements including profit or loss, financial position, cash flows, notes to the financial statements, directors' report, and auditor's review report. The presence of comprehensive financial data and analysis for the half-year period confirms it is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or certification. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2025
2024-11-26 English
Cancel - Notification of cessation of securities - LGP 4 pages 14.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cancellation of a previous announcement regarding securities (performance rights) that have ceased due to lapse of conditional rights. It includes specific information about securities codes, numbers, cessation reasons, and issued capital following changes. The document is a regulatory announcement related to changes in securities status, specifically cessation of securities, which aligns with a Major Shareholding Notification or similar capital structure update. However, since it is about cessation of securities and not about shareholding thresholds or voting results, the best fit is a Share Issue/Capital Change (SHA) category, which covers announcements regarding capital changes including securities cessation. The document length is 4034 characters, which is short but contains substantive information about securities changes, not just a report publication or a brief notice. Therefore, it is not a Report Publication Announcement or Regulatory Filing fallback. Hence, the classification is SHA with high confidence.
2024-11-25 English
Notification of cessation of securities - LGP 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities (share rights) for LITTLE GREEN PHARMA LTD. It includes specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is a formal announcement to the ASX about changes in the company's securities, specifically the cessation of certain securities. This type of document is a regulatory announcement related to securities but does not constitute a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive details about the cessation event itself. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-11-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.